J2 Capital Management Inc Ab Cellera Biologics Inc. Transaction History
J2 Capital Management Inc
- $120 Million
- Q2 2025
A detailed history of J2 Capital Management Inc transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, J2 Capital Management Inc holds 13,100 shares of ABCL stock, worth $66,941. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,100Holding current value
$66,941% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ABCL
# of Institutions
153Shares Held
132MCall Options Held
156KPut Options Held
346K-
Baker Bros. Advisors LP New York, NY27.5MShares$141 Million0.73% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL15.7MShares$80.1 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$68.3 Million0.01% of portfolio
-
Baillie Gifford & CO11.2MShares$57.2 Million0.02% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$54.3 Million0.03% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.46B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...